Biden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough? Opens in a new window)
Nearly six months into his term, Biden issued an executive order on promoting economic competition, which included moves toward fulfilling these promises.
The U.S. Food and Drug Administration has approved a new use for Prograf (tacrolimus) based on a non-interventional (observational) study providing real-world evidence (RWE) of effectiveness.
The litigation followed a public outcry in 2016 after Mylan, which owns the rights to market and distribute the devices, raised the price of a pair of EpiPens to $600, from $100 in 2008.
How price indices are used to compare prescription drug prices between countries.
U.S. FTC announces multi-national working group to build a new approach to biopharmaceutical mergers.